Get the Stockscreener App
5.39
2.53%
-0.14
After Hours:
5.39
Sight Sciences Inc stock is traded at $5.39, with a volume of 233.94K.
It is down -2.53% in the last 24 hours and down -27.26% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$5.53
Open:
$5.59
24h Volume:
233.94K
Relative Volume:
0.84
Market Cap:
$284.98M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-4.7281
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-5.27%
1M Performance:
-27.26%
6M Performance:
+26.82%
1Y Performance:
+110.55%
1-Day Range:
$5.32
$5.62
1-Week Range:
$5.32
$6.15
52-Week Range:
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
5.39 | 292.38M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
KCK LTD. Adjusts Holdings in Sight Sciences Inc: A Strategic Por - GuruFocus
Chart Watch: Will Sight Sciences Inc outperform tech stocks2025 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
Aug Action: Is Sight Sciences Inc on track to beat earningsBear Alert & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Market Catalysts: Is Sight Sciences Inc subject to activist investor interest2025 Pullback Review & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sight Sciences extends Menlo Park headquarters lease with rent abatement period By Investing.com - Investing.com India
Sight Sciences extends Menlo Park headquarters lease with rent abatement period - Investing.com Canada
Sight Sciences Extends Menlo Park Headquarters Lease Agreement - TipRanks
Sight Sciences (NASDAQ:SGHT) Raised to “Strong-Buy” at William Blair - Defense World
Sight Sciences (NASDAQ:SGHT) Raised to Strong-Buy at William Blair - MarketBeat
William Blair resumes Sight Sciences stock with Outperform rating By Investing.com - Investing.com Australia
William Blair resumes Sight Sciences stock with Outperform rating - Investing.com
Sight Sciences (NASDAQ:SGHT) and Vaso (OTCMKTS:VASO) Head to Head Survey - Defense World
Sight Sciences (SGHT) chief legal officer sells $41,758 in stock By Investing.com - Investing.com UK
Sight Sciences CEO Badawi sells $148k in shares By Investing.com - Investing.com Canada
Sight Sciences (SGHT) chief legal officer sells $41,758 in stock - Investing.com
Sight Sciences CEO Badawi sells $148k in shares - Investing.com
David Badawi Sells 4,836 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Paul Badawi Sells 22,362 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Jeremy Hayden Sells 6,308 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Insider Selling: Sight Sciences (NASDAQ:SGHT) CFO Sells 2,616 Shares of Stock - MarketBeat
Badawi, Sight Sciences CTO, sells $32k in shares - Investing.com
Badawi, Sight Sciences CTO, sells $32k in shares By Investing.com - Investing.com South Africa
Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge Could Signal Some Risk - simplywall.st
Americana Partners LLC Grows Stock Holdings in Sight Sciences, Inc. $SGHT - MarketBeat
Fed Watch: Is Sight Sciences Inc on track to beat earningsJuly 2025 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Sight Sciences’ Helix Surgical System Study: A Potential Game-Changer for Glaucoma and Cataract Treatment - MSN
Aug PostEarnings: Will Sight Sciences Inc benefit from sector rotationPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Sight Sciences Releases Preliminary Q4 and 2025 Financial Results - VisionMonday.com
Sight Sciences (SGHT) Price Target Increased by 19.11% to 9.54 - Nasdaq
Sight Sciences reports Q4 revenue growth amid dry eye milestones By Investing.com - Investing.com Nigeria
Sight Sciences announces preliminary, unaudited fourth quarter and full year 2025 financial highlights - marketscreener.com
Sight Sciences Reports Preliminary Fourth Quarter and Full Year 2025 Financial Highlights - Quiver Quantitative
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights - marketscreener.com
Sight Sciences reports Q4 revenue growth amid dry eye milestones - Investing.com
Aug Rallies: Can Sight Sciences Inc be recession proofMarket Performance Recap & Fast Entry and Exit Trade Plans - baoquankhu1.vn
S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Technical Overview & Technical Confirmation Alerts - baoquankhu1.vn
Sight Sciences (SGHT) – Analysts’ Recent Ratings Changes - Defense World
Looking At The Narrative For Sight Sciences SGHT After Medicare Coverage Shifts - Yahoo Finance
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by Brokerages - MarketBeat
This Insider Has Just Sold Shares In Sight Sciences - Sahm
Will Sight Sciences Inc. stock maintain dividend yieldMarket Weekly Review & Weekly Top Gainers Trade List - Улправда
Sight Sciences, Inc.'s (NASDAQ:SGHT) largest shareholders are individual investors with 30% ownership, institutions own 25% - Yahoo Finance
Rodberg, Sight Sciences CFO, sells $38,890 in SGHT stock By Investing.com - Investing.com India
Sight Sciences (SGHT) CTO Badawi sells $73k in stock By Investing.com - Investing.com Canada
Sight Sciences (SGHT): chief legal officer Hayden sells $86k in stock By Investing.com - Investing.com South Africa
Sight Sciences (SGHT) CTO Badawi sells $73k in stock - Investing.com
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):